Over 1.5 million are diagnosed with breast cancer every year. It's a frightening statistic.
As the most common cancer in women and the second most common cancer across both genders, breast cancer is one of the most pressing global issues. Studies have shown that earlier diagnosis and better methods of treatment with higher specificity and potency could potentially reduce mortality rates by 30-40%.
But we have a solution.
In a nutshell, our envisioned approach incorporates a computer interface that uses fractal dimensional analysis of a patient's MRA scan to identify the location of the primary tumor and then delivers thermal injections of polymethyl methacrylate (PMMA) nanoparticles to the identified location in order to target cancer-specific cells and prevent recurrences of breast cancer.